$XTLB· SEC filing ·

XTLB Reports $0 Revenue, $0 EPS, No Deals, Israel-Based Biopharma

XTL Biopharmaceuticals Ltd. American Depositary Shares · Now $2.40

-4.9% in 1d after detection

Post-detection moves

1h
1d
-4.9%
3d
-2.2%
7d
+1.2%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS